Merit Medical Systems, Inc.
MMSIMedical Instruments & Supplies
$86.24−7.66%As of Oct 30vs prior close
- Market cap
- $5.2B
- P/E (TTM)
- 32.1×
- P/E (FY1)
- 20.0×
- From 52W high
- −8.45%
- EPS (LTM)
- $2.67
- Revenue (LTM)
- $1.6B
- Net margin
- 9.94%
- Dividend yield
- 0.00%
Nomior Score
59
Steady ProfileSpeculativeTop 29% of the scored universe
Growth50
Quality68
Value56
Momentum42
Resilience63
Growth
+10.77%revenue a year over 9 fiscal years
FY16 $603.8MLTM $1.6B
Connections
Revenue to profitQ3 FY26
10% of revenue became net profit, up 3 pts on a year.
Latest resultsthird quarter 2026
- Revenue
- $416.2 million
- Net income
- $42.3 million
- Adjusted EPS
- $1.12
Merit reported higher third-quarter sales and profit, led by organic constant currency growth with strength in the U.S. and across both its Foundational and Therapeutic platforms. Non-GAAP earnings per share grew and the company raised its full-year revenue and non-GAAP earnings per share guidance. Year-to-date cash flow from operations and free cash flow were solid, and a longer-term strategic plan is being finalized.
Who owns it
2funds, 1 tracked portfolio